Genetically engineered yeast makes medicinal plant products

José Montaño López and José L. Avalos ()

Nature, 2020, vol. 585, issue 7826, 504-505

Abstract: Yeast has been engineered to convert simple sugars and amino acids into drugs that inhibit a neurotransmitter molecule. The work marks a step towards making the production of these drugs more reliable and sustainable.

Keywords: Biotechnology; Synthetic biology; Microbiology (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/d41586-020-02461-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:585:y:2020:i:7826:d:10.1038_d41586-020-02461-8

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-020-02461-8

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().